164 related articles for article (PubMed ID: 30978313)
1. A biophysical study of the interactions between the antimicrobial peptide indolicidin and lipid model systems.
Nielsen JE; Lind TK; Lone A; Gerelli Y; Hansen PR; Jenssen H; Cárdenas M; Lund R
Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1355-1364. PubMed ID: 30978313
[TBL] [Abstract][Full Text] [Related]
2. Resolving the structural interactions between antimicrobial peptides and lipid membranes using small-angle scattering methods: the case of indolicidin.
Nielsen JE; Bjørnestad VA; Lund R
Soft Matter; 2018 Nov; 14(43):8750-8763. PubMed ID: 30358793
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of antimicrobial peptide action: studies of indolicidin assembly at model membrane interfaces by in situ atomic force microscopy.
Shaw JE; Alattia JR; Verity JE; Privé GG; Yip CM
J Struct Biol; 2006 Apr; 154(1):42-58. PubMed ID: 16459101
[TBL] [Abstract][Full Text] [Related]
4. An atomic force microscopy study of the interactions between indolicidin and supported planar bilayers.
Askou HJ; Jakobsen RN; Fojan P
J Nanosci Nanotechnol; 2008 Sep; 8(9):4360-9. PubMed ID: 19049026
[TBL] [Abstract][Full Text] [Related]
5. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial peptide alamethicin insertion into lipid bilayer: a QCM-D exploration.
Wang KF; Nagarajan R; Camesano TA
Colloids Surf B Biointerfaces; 2014 Apr; 116():472-81. PubMed ID: 24561501
[TBL] [Abstract][Full Text] [Related]
7. Differentiating antimicrobial peptides interacting with lipid bilayer: Molecular signatures derived from quartz crystal microbalance with dissipation monitoring.
Wang KF; Nagarajan R; Camesano TA
Biophys Chem; 2015 Jan; 196():53-67. PubMed ID: 25307196
[TBL] [Abstract][Full Text] [Related]
8. Arginine-Containing Surfactant-Like Peptides: Interaction with Lipid Membranes and Antimicrobial Activity.
Castelletto V; Barnes RH; Karatzas KA; Edwards-Gayle CJC; Greco F; Hamley IW; Rambo R; Seitsonen J; Ruokolainen J
Biomacromolecules; 2018 Jul; 19(7):2782-2794. PubMed ID: 29738229
[TBL] [Abstract][Full Text] [Related]
9. Atomic Force Microscopy to Characterize Antimicrobial Peptide-Induced Defects in Model Supported Lipid Bilayers.
Swana KW; Nagarajan R; Camesano TA
Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576869
[TBL] [Abstract][Full Text] [Related]
10. Effect of antimicrobial peptide-amide: indolicidin on biological membranes.
Végh AG; Nagy K; Bálint Z; Kerényi A; Rákhely G; Váró G; Szegletes Z
J Biomed Biotechnol; 2011; 2011():670589. PubMed ID: 21765635
[TBL] [Abstract][Full Text] [Related]
11. Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids.
Ladokhin AS; Selsted ME; White SH
Biophys J; 1997 Feb; 72(2 Pt 1):794-805. PubMed ID: 9017204
[TBL] [Abstract][Full Text] [Related]
12. Indolicidin action on membrane permeability: carrier mechanism versus pore formation.
Rokitskaya TI; Kolodkin NI; Kotova EA; Antonenko YN
Biochim Biophys Acta; 2011 Jan; 1808(1):91-7. PubMed ID: 20851098
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic predictions of the influence of collagen-binding domain sequences on human LL37 interactions with model lipids using quartz crystal microbalance with dissipation.
Lozeau LD; Rolle MW; Camesano TA
Biointerphases; 2019 Apr; 14(2):021006. PubMed ID: 31039613
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations of indolicidin association with model lipid bilayers.
Hsu JC; Yip CM
Biophys J; 2007 Jun; 92(12):L100-2. PubMed ID: 17416617
[TBL] [Abstract][Full Text] [Related]
15. Ib-AMP4 insertion causes surface rearrangement in the phospholipid bilayer of biomembranes: Implications from quartz-crystal microbalance with dissipation.
Fan X; Korytowski A; Makky A; Tanaka M; Wink M
Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):617-623. PubMed ID: 29106975
[TBL] [Abstract][Full Text] [Related]
16. Characterization of supported lipid bilayer disruption by chrysophsin-3 using QCM-D.
Wang KF; Nagarajan R; Mello CM; Camesano TA
J Phys Chem B; 2011 Dec; 115(51):15228-35. PubMed ID: 22085290
[TBL] [Abstract][Full Text] [Related]
17. Biological activity and structural aspects of PGLa interaction with membrane mimetic systems.
Lohner K; Prossnigg F
Biochim Biophys Acta; 2009 Aug; 1788(8):1656-66. PubMed ID: 19481533
[TBL] [Abstract][Full Text] [Related]
18. Cationic peptide-induced remodelling of model membranes: direct visualization by in situ atomic force microscopy.
Shaw JE; Epand RF; Hsu JC; Mo GC; Epand RM; Yip CM
J Struct Biol; 2008 Apr; 162(1):121-38. PubMed ID: 18180166
[TBL] [Abstract][Full Text] [Related]
19. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
Ramamoorthy A; Thennarasu S; Tan A; Gottipati K; Sreekumar S; Heyl DL; An FY; Shelburne CE
Biochemistry; 2006 May; 45(20):6529-40. PubMed ID: 16700563
[TBL] [Abstract][Full Text] [Related]
20. Design and use of model membranes to study biomolecular interactions using complementary surface-sensitive techniques.
Clifton LA; Campbell RA; Sebastiani F; Campos-Terán J; Gonzalez-Martinez JF; Björklund S; Sotres J; Cárdenas M
Adv Colloid Interface Sci; 2020 Mar; 277():102118. PubMed ID: 32044469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
